- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 1 - Prevalence of Diabetes and Obesity in the United States
Recognizing that the prevalence of both obesity and type 2 diabetes mellitus (T2DM) are on the rise in the United States, Peter Salgo, MD, explains how the 2 diseases march hand-in-hand and have a major impact on US healthcare spending.
Dr Salgo explains that the prevalence of T2DM increases with weight and states that the annual costs associated with T2DM are approximately $245 billion. The cost burden of T2DM is reflected in both direct expenditures and costs associated with lost productivity and absenteeism.
Kari Uusinarkaus, MD, FAAFP, FNLA, and Yehuda Handelsman, MD, FACP, FACE, FNLA, discuss how the trends are noticeable in each of their respective US states.
Jeffrey D. Dunn, PharmD, MBA, describes how the diabetes and obesity epidemics, combined with life expectancies, an aging population, comorbidities, and drug prices, exert a substantial burden on society.
Maria Lopes, MD, MS, explains how educational efforts and resources that help support patients can help empower patients to take responsibility for their health. Dr Handelsman suggests that a nationwide government-directed intervention is necessary to reverse the trend of increasing obesity prevalence.
Managed Care Reflections: A Q&A With A. Mark Fendrick, MD, and Michael E. Chernew, PhD
December 2nd 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The December issue features a conversation with AJMC Co–Editors in Chief A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design and a professor at the University of Michigan in Ann Arbor; and Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy and the director of the Healthcare Markets and Regulation Lab at Harvard Medical School in Boston, Massachusetts.
Read More
